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Abstract: We examine whether modeling of the causal dynamic relationships between frontal and occipital 
electroencephalogram (EEG) time-series recordings reveal reliable differentiating characteristics of Alzheimer's patients 
versus control subjects in a manner that may assist clinical diagnosis of Alzheimer's disease (AD).  The proposed modeling 
approach utilizes the concept of Principal Dynamic Modes (PDM) and their associated nonlinear functions (ANF) and 
hypothesizes that the ANFs of some PDMs for the AD patients will be distinct from their counterparts in control subjects.  To 
this purpose, "global" PDMs are extracted from 1-min EEG signals of 17 AD patients and 24 control subjects at rest using 
Volterra models estimated via Laguerre expansions, whereby the O1 or O2 recording is viewed as the "input" signal and the 
F3 or F4 recording as the "output" signal.  Subsequent singular value decomposition (SVD) of the estimated Volterra kernels 
yields the global PDMs that represent an efficient basis of functions for the representation of the EEG dynamics in all 
subjects.  The respective ANFs are computed for each subject and characterize the specific dynamics of each subject.  For 
comparison, signal features traditionally used in the analysis of EEG signals in AD are computed as benchmark.  . The results 
indicate that the ANFs of two specific PDMs, corresponding to the delta-theta and alpha bands, can delineate the two groups 
well. 
 
 
     I.  INTROCUTION 
LZHEIMER’S DISEASE (AD) is the most common 
neurodegenerative disorder in the western world and 
the number of patients is expected to double 
approximately every 20 years because of the aging 
population [6]. AD is characterized by the accumulation of 
amyloid plaques and neurofibrillary tangles in the patient’s 
brain and loss of cortical neurons and synapses [7]. These 
pathological changes cause memory loss and 
other cognitive and behavioral impairments that 
progressively affect the patient’s ability to live 
independently [7]. 
The guidelines for clinical diagnosis of AD [8] are based 
on the exclusion of other causes for the symptoms. However, 
a definite diagnosis of AD can only be made by necropsy [7] 
and AD pathology is hypothesized to start years before the 
first symptoms appear. The patient’s quality of life already 
affected by the time clinical diagnosis is made [7]. Thus, 
there is a need for objective, non-invasive and affordable 
means to support clinicians in the detection and monitoring 
of AD. One of such potential means is the analysis of 
electroencephalogram (EEG) recordings [9]. 
The analysis of EEG time series has been explored 
previously for its diagnostic potential in AD, based on the 
notion that the EEG signals represent fluctuations of 
aggregate brain activity in the respective brain regions and,    
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therefore, may be able to reveal differences in brain function 
under different clinical conditions [10], [11].  Many previous 
studies have explored this question through the computation 
of diverse signal features from EEG recordings [10], [11]. 
Spectral features, including both spectral indices such as 
median frequency and relative power values, have revealed a 
spectral slowdown of the brain activity in AD [9]-[12]. 
Nonlinear features provide additional points of view in the 
inspection of the EEG signals. Features such as Sample 
Entropy have been applied to the EEG recordings of patients 
[11]. The results indicate that AD affects the nonlinear 
characteristics of the EEG signals, making them more 
regular and predictable [10], [11]. 
AD is hypothesized to be a disconnection syndrome 
[10],[13]. Therefore, there is increasing interest in the 
inspection of the connectivity of EEG recordings [10], 
[13],[14],[16],[17].This is often evaluated by measuring the 
(linear or nonlinear) dependencies between two signals in 
different spectral bands [10],[14], [17]. This is particularly 
important in AD as the disease may cause opposing changes 
in different frequency ranges [10], [13], [16]. 
Traditional approaches to measure the connectivity 
between EEG signals are limited by a number of factors. To 
start with, spurious results could appear due to the volume 
conduction effects [13], [16], [17], because nearby channels 
are likely to record activity from identical sources. Ideally, 
the connectivity evaluation should also inform about the 
causality of the interactions between signals [17]. While 
some techniques have been recently developed to address 
these issues (e.g., phase lag index in [13]), their use is 
limited perhaps due to a less straightforward interpretation 
than other techniques. 
As an alternative, the present study focuses on the 
modeling and analysis of the possible causal relationship 
between occipital recordings (viewed as the "input" signal) 
and frontal recordings (viewed as the "output" signal) in 
order to generate model-based indices to characterize the 
EEGs of AD patients.  To this purpose, we apply the 
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Volterra modeling approach using Laguerre expansions of 
the kernels and employ the concept of Principal Dynamic 
Modes (PDM), which our group has pioneered  [4].  This 
reduces significantly the required number of free parameters 
in the model and enables estimation of reliable linear or 
nonlinear dynamic models under conditions of low SNR. 
This modeling methodology has been recently applied to 
many different physiological domains, including the cerebral 
hemodynamics in AD patients [5].  The results to date 
corroborate the potential and efficacy of this modeling 
approach.  The proposed diagnostic indices in this study are 
generated through the use of the Associated Nonlinear 
Functions (ANFs) that correspond to each PDM of each 
subject.  
    Our aim is to examine whether the estimated PDMs 
exhibit spectral characteristics in line with the neural 
rhythms naturally occurring in the brain (delta, theta, alpha 
and beta, and gamma) and whether the ANFs obtained for 
each subject can be used as descriptors of disease.  It is 
posited that these ANFs may constitute useful "features" for 
the classification and differentiation of overall cognitive 
function in AD patients versus controls. 
 
II.  METHODS 
A.  Data Collection and Pre-processing 
This study involves 24 control subjects (42% male; 
average age: 69.4±11.5 years, mean±standard deviation, SD) 
and 17 AD patients (53% male; average age: 77.6±10.0 
years) who voluntarily participated and signed the Informed 
Consent Form according to institutional guidelines.   
The EEG recordings were obtained for patients at rest and 
with their eyes closed, using the traditional 10–20 system in 
a Common Reference montage using a sampling rate of 256 
Hz. The signals were downsampled to 128Hz offline. 
The data were obtained under a strict protocol from 
Derriford Hospital, Plymouth, UK, and had been collected 
using normal hospital practices. The patients were referred 
to the hospital EEG department from a specialist memory 
clinic where all patients undergo a battery of psychometric 
tests before referral. The results from the psychometric tests 
were scored and interpreted by a specialist psychologist. 
Each patient was given a diagnosis at the memory clinic on 
the basis of the clinical and psychometric findings and 
discussions held by a multidisciplinary team. Each patient 
was then referred to the hospital for EEG assessment. All 
age-matched controls were healthy volunteers and had 
normal EEGs (confirmed by a Consultant Clinical 
Neurophysiologist). 
For each subject, continuous epochs of 60 seconds were 
simultaneously extracted from the left frontal (F3), right 
frontal (F4), left occipital (O1) and right occipital (O2) 
channels. The selection of these electrodes is supported by 
the fact that AD is hypothesized to affect long-range 
connectivity as a result of the loss of long cortico-cortical 
association fibers, which may play an important role in 
functional interactions [10]. Moreover, selecting nearby 
channels would probably result in all of them picking up 
identical sources, which may lead to spurious connectivity 
levels reflecting simple volume conduction rather than true 
functional connectivity [13]. The positions of the selected 
electrodes minimize possible effects of  ocular activity. 
The epochs of 60s were selected for having a small 
presence of artifacts. They were then band-pass filtered in 
the range of 1 to 40 Hz with a band-pass Hamming window 
FIR filter with order 200. The data were then demeaned and 
scaled by a factor of 1/100 for computational/numerical 
convenience. Fig.1 shows illustrative pre-processed time-
series data over 3 sec and the respective spectrogram for the 
O1 EEG signal of an AD patient.  The spectral properties of 
this data segment seem stationary. 
 
 
Fig. 1.  Top panel: illustrative time-series data over 3 sec from the O1 EEG 
signal of AD patient #1. Bottom panel: the spectrogram over 60 sec of the 
time-series data up to 40Hz for this patient. 
B.  Modeling Methodology 
The proposed modeling approach utilizes the concept of 
Principal Dynamic Modes (PDM) that has been pioneered 
by our group and applied successfully over the last 10 years 
to various physiological systems [4].  In this approach, we 
seek to determine from input-output data a set of basis 
functions (the PDMs) that represent an efficient “coordinate 
system” for the representation of the Volterra kernels of a 
given class of systems.  Static nonlinear functions associated 
with each PDM (termed ANF: Associated Nonlinear 
Functions) describe the (possible) nonlinearities of the 
system.  The PDM modeling approach relies on an efficient 
methodology for the estimation of Volterra kernels using 
Laguerre expansions [4]. To reduce the complexity of the 
obtained PDM-based models and facilitate comparisons 
between different cohorts, we seek to determine the "global" 
PDMs of a given system from the estimated kernels of a 
cohort.  This is accomplished through singular value 
decomposition (SVD) of a rectangular matrix containing all 
estimated Volterra kernels in the cohort. We note that the 
computation of the global PDMs must be based on all 
subjects because they represent a common frame of 
reference for all subjects who are subsequently classified 
according to their respective ANFs.  The global PDMs 
correspond to the selected “significant” singular vectors by 
applying a selection criterion on the respective singular 
values.  
   In this study, we analyze the causal relationship between 
two EEG signals, in which the frontal signal is taken as the 
"output" and the occipital signal is taken as the "input". 
Using the Laguerre expansion technique, we start with linear 
modeling (1st order Volterra kernel only) and proceed with 
nonlinear modeling estimating the 2nd-order Volterra 
kernels as well.  These kernel estimates are used to compute 
the global PDMs of these cohorts via SVD of a rectangular 
matrix that contains either all the 1st order kernels (Method 
1) or the 1st and 2nd order kernels (Method 2) for all 
subjects (patients and controls).  The resulting PDMs are 
used to obtain nonlinear models of 5th order.  The key to the 
model estimation problem is the use of the Laguerre 
expansion technique that keeps the number of free 
parameters manageable for all models.  A detailed 
description of this methodology is given in the monograph 
[4].  We summarize below the methodology of PDM-based 
modeling. The 1st order (linear) Volterra model is: 
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where  
- x(n) is the input (occipital)signal 
- y(n) is the output(frontal) signal 
- {k0, k1} are the zeroth order kernel (constant) and 
the first order kernel respectively 
- M is the system memory (M=70 here) 
To limit the number of free parameters that must be 
estimated, the kernels are expanded onto a basis of 
orthonormal discrete Laguerre functions    {𝑏𝑗}  (𝑗 =
1,2 … 𝐿). In this study, 7 discrete Laguerre functions with 
Laguerre parameter 0.6 (L = 7 , α = 0.6)  are found to be 
adequate to represent the input-output dynamic relations. 
The optimal value of the Laguerre parameter  α and L is 
determined through a global search procedure that 
minimizes the normalized mean square error (NMSE) of the 
model prediction for all subjects.  The selected values of 
alpha and L determine the system memory (M=70 in this 
case). After Laguerre expansion, the linear model is given by 
the expression: 
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The 8 expansion coefficients (c0, c1) are estimated by the 
ordinary least-squares method and the 1st order kernel 
estimate is given by the expression: 
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This model has 8 free parameters, as compared to 71 free 
parameters for the original linear Volterra model. 
     The second-order Volterra model is given by: 
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where k2 denotes the 2nd order kernel.  Following the 
Laguerre expansion technique (L=7), we have:  
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The number of free parameters in this model is 36, as 
compared to 2556 free parameter for the original 2nd order 
Volterra model. The 2nd order Volterra kernel is expressed 
in terms of the expansion coefficients as:    
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The PDM-based modeling approach seeks to find the 
“minimum set” of basis functions (the "global" PDMs) that 
are able to represent the input-output dynamics adequately 
for each particular system.  This is achieved via SVD of a 
rectangular matrix composed of the estimated Volterra 
kernels of the respective cohort using either of two methods: 
 
Method 1: the kernel-based matrix is composed of the 1st 
order kernel estimates for all subjects; 
Method 2: the kernel-based matrix is composed of the 1st 
and 2nd order kernel estimates for all subjects. 
 
In both methods, the global PDMs are determined as the 
significant singular vectors of the kernel-based matrix that 
correspond to singular values satisfying a specified selection 
criterion (e.g. at least 10% of the maximum singular value).  
In this study, 5 to 6 global PDMs were selected.  The 
physiological characteristics of these global PDMs will be 
discussed in the following section. The global PDMs are 
used to describe the dynamics of this system (via expansions 
of the system kernels) for all subjects.  The possible 
nonlinearities of the system are described by the respective 
ANFs, which are subject-specific and can be used for 
diagnostic purposes.  The case of linear models is included 
in this representation, when the ANFs are linear functions.  
The output equation for the PDM-based model is: 
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where 
- 𝑝𝑖  is the ith global PDM 
- H is the number of global PDMs 
- fi is the ANF of the ith PDM 
 
In general, the ANFs are taken to be polynomials (typically 
of 3rd degree): 
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The polynomial ANF can be replaced by its best linear fit (in 
a least-squares sense) if reduction of model complexity is 
desirable.  In that case, the linear coefficient is an "effective 
gain constant" for the respective PDM and can be used as an 
index for delineating AD patients from control subjects.  
Fig.2 shows a schematic block-diagram of the PDM-
based model. 
 
 
  
Fig. 2.  Block-diagram of the PDM-based model of the O1-F3 system with 
5 global PDMs. The output 𝑢𝑗of the jth PDM 𝑝𝑗 is the convolution of the 
PDM with the input signal.  In this study, the ANFs are taken to be the 5th 
degree polynomials: 𝑧𝑗 = 𝑎1,𝑗𝑢𝑗 + 𝑎2,𝑗𝑢𝑗
2 + 𝑎3,𝑗𝑢𝑗
3 + 𝑎𝑗,4𝑢𝑗
4 + 𝑎𝑗,5𝑢𝑗
5 based 
on a search procedure that yields the best classification results for the 
smallest number of free parameters.  
 
C. Spectral and Nonlinear Signal Features 
As benchmark, we also compute a number of features that 
have been reported to characterize the EEG signals in AD 
[9]-[11]. For each EEG electrode, we compute its: relative 
power (RP) in δ (1Hz–4Hz; RPδ), θ (4Hz–8Hz; RPθ), α 
(8Hz–13Hz; RPα), β (13Hz–30Hz; RPβ) and γ (30Hz–40Hz; 
RPγ) bands; median frequency (MF); and Sample Entropy 
(SE). The RP features provide a holistic view of the 
frequency spectrum of the signals [10], whereas MF and SE 
are two indices that summarize the spectral and nonlinear 
changes introduced in the brain activity by AD [11], [15]. 
Finally, we also compute a classical metric of connectivity 
between frontal and occipital channels: spectral coherence: 
c(f) [10], [17]. 
 
1) Relative Power(RP) 
The assessment of spectral characteristics of the EEG 
activity is based on the power spectral density (PSD) of each 
EEG epoch, which is computed as the Fourier transform of 
its autocorrelation function [11]. The PSDs obtained from 
segments of 10s of each channel and subject are averaged to 
compute the mean PSD corresponding to that channel and 
subject. Then, the PSD is normalized by the total power in 
the considered broadband (1Hz to 40Hz) to obtain a 
normalized PSD (PSDn) [15]: 
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If flow and fhigh are the low and high cut-off frequencies of 
each band (e.g., flow=1Hz and fhigh=4Hz for δ), the RP is 
calculated from the PSDn using [15]: 
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2) Median Frequency (MF) 
MF is a simple index that quantifies the relative strength of 
low- and high-frequency oscillations. It is defined as the 
frequency value that separated the frequency range of the 
PSDn in two bands so that each of them contained half the 
PSDn power [15]: 
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3) Sample Entropy (SE) 
Approximate entropy is a commonly used metric to quantify 
irregularity in biomedical recordings. It evaluates the 
appearance of repetitive patterns in the data [9]. However, 
this statistic is biased as it counts each sequence as matching 
itself to avoid the occurrence of log(0) in the computations. 
To reduce this bias, SE was introduced as a modification of 
approximate entropy [11]. 
SE is an irregularity metric that assigns higher values to 
more irregular signals. SE has two input parameters: a run 
length m and a tolerance window r. The time series are split 
into segments of 10s and the SE is estimated with m=1 and 
r=0.25 times the SD of the signal. Then, the SE is averaged 
across all segments from the same electrode and subject 
[11].  A detailed description of the algorithm and additional 
details are available elsewhere [11]. 
 
4) Spectral Coherence 
Additionally, c(f) is used as a benchmark to measure 
connectivity between pairs of EEG channels. c(f) is a 
function of frequency accounting for linear synchronization 
between two signals and it is bounded between 0 and 1, [10], 
[14], [17]. However, it does not discriminate the 
directionality of the coupling [14], [17]. Decreased 
coherence indicates reduced functional connections between 
EEG electrodes or reduced common modulation of the two 
areas by a third one [10]. 
Two EEG epochs of equal length—x(t) and y(t)—are 
divided into B equal blocks of 1s each with 50% overlap on 
the basis of previous analyses [14], [16]. c(f) is computed as 
[14], [16]: 
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where X(f) and Y(f) are the Fourier transforms of x(t) and 
y(t), respectively. *, | · |, and < > denote complex conjugate, 
magnitude and average over the B blocks, respectively [14], 
[16]. 
 
5) Phase Slope Index:(PSI) 
The concept of phase synchrony may also be used to 
measure dependencies between EEG signals by examining.  
The interdependence between the corresponding phases, 
which may be strongly synchronized even if the amplitudes 
of the signals are statistically independent [14]. A causal 
relationship between two signals at a certain time lag 
appears as a constant proportionality between cross-spectral 
phase and frequency. We will use the PSI to estimate such 
direction of information flow robustly even in the presence 
of independent background activity [19]. 
 
 
III.  RESULTS 
A. Modeling  
    The predictive capability of the obtained PDM-based 
model is assessed by the Normalized Mean Square Error 
(NMSE) of the respective model prediction. The minimum 
NMSE among the four combinations of occipital-to-frontal 
input-output systems was obtained for the nonlinear model 
of the O1-to-F3 system (NMSE=89.7 %), only slightly better 
than its linear counterpart (NMSE= 91.2 %).  It is evident 
that the model prediction only accounts for a small portion 
of the output signal, but this should be expected in a system 
of such low signal-to-noise ratio. 
     5 PDMs for the O1-to-F3 model were obtained using 
Method 2. For the sake of clarity, only 4 PDMs are shown in 
Fig.3 and Fig.4 for the frequency-domain and time-domain 
respectively. In the frequency domain (Fig.3), the global 
PDMs exhibit spectral characteristics that correspond to the 
following neural rhythm bands:  
-   1st PDM (red): beta band (~20 Hz)  
-   2nd PDM (blue): alpha band (~12 Hz)  
-   3rd PDM (green): low delta band (~1 Hz); 
-  4th PDM (magenta): combination of theta (~8 Hz)      with 
delta band (~3 Hz);  
-   5th PDM (black): high delta (~4 Hz). 
 
The 2nd and 4th PDMs were found to be the most 
differentiating between AD patients and control subjects (see 
below). 
     The average Associated Nonlinear Functions (ANFs) for 
the nonlinear models of the O1-to-F3 system (defined as 5th 
degree polynomials in this application) are shown in Fig.5 
with blue line for the 17 AD patients (bottom row) and the 
24 control subjects (top row), along with the best (in mean-
square sense) linear fits shown in gray .  It is evident in Fig.5 
that the slope of the 4th ANF changes sign for the patients 
(i.e. becomes positive for the AD patients from negative for 
the controls), and the negative slopes of the 3rd and 5th 
ANFs decrease (in absolute value) for the patients.  This 
suggests that these three PDMs are more likely to provide 
the means for differentiation between patients and controls.  
However, the difference between the average values of ANF 
slopes may not portray correctly the separation between the 
two groups which relies on the distribution of the individual 
values. 
 
 
Fig. 3.  Frequency-domain representations of the global PDMs of the input-
output model for the O1-to-F3 system (four out of five PDMs are plotted for 
the sake of clarity, see text). 
 
 
 
Fig. 4.  Time-domain representations of the  global PDMs of the input-
output model for the O1-to-F3 system(four out of five PDMs are plotted for 
the sake of clarity, see text). 
 
 
 
Fig. 5.  Average ANFs (blue line) for the 5 PDMs of the 17 AD patients 
(bottom row) and 24 control subjects (top row), along with the best linear 
fits (gray line) for the O1-to-F3 system. 
 
   After examining the differentiating capability of all pair 
combinations of PDMs/ANFs, it was found that the 2nd and 
4th PDMs (Fig.8, and their respective linear trends) are the 
most differentiating between patients and controls for O2-F3 
system, as shown in the scatter-plot of Fig.6.  They result in 
one false-positive (#40) and two false-negatives (#3 and 
#17).  The sensitivity of 88.2 % and specificity of 95.8 % are 
marked on the corresponding ROC curve shown in Fig.7. 
We note that satisfactory delineation between the two 
groups is also achieved in the O1-F3 system (see scatter-plot 
in Fig.9) using the pair of 2nd and 4th PDMs/ANFs that 
correspond to the alpha-delta and theta-delta bands 
respectively, as shown in Fig.3. Two false-negatives (#13, 
#17) result in this case (sensitivity of 88.2 %) and two false-
positives (#29,#40. 91.7% specificity).  This suggests that 
the use of more than two PDMs/ANFs ought to be explored 
for differentiation of patients from controls.  
 
 
Fig. 6.  Scatter-plot of computed ANF linear trends (slopes) for 2nd and 4th 
PDMs of the O2-to-F3 system, corresponding to the alpha-delta and theta-
delta bands. One false-positive and two false-negatives are shown. The 
classification line has been obtained by nonlinear regression  algorithm . 
(with 150 000 iterations).
 
 
Fig. 7. ROC curve for the scatter-plot of Fig.6 (2nd versus 4th ANF/PDMs) 
of the O2-to-F3 system. 
 
 
Fig. 8. Frequency-domain representations of  global PDMs of the input-
output model for the O2-to-F3 system (four out of six PDMs are plotted for 
the sake of clarity, see text). 
 
Fig. 9.  Scatter-plot of computed ANF linear trends (slopes) for 2nd and 4th 
PDMs of the O1-to-F3 system, corresponding to the alpha-delta and theta-
delta bands. Two false-negatives and two false-positives are shown.  
 
 
B. Benchmark Features 
A number of features were computed from the same EEG 
signals, including the RPs in five spectral bands, MF and SE. 
These features were calculated from single channels in 
contrast with the PDM modeling. However, they have been 
reported to discriminate between the electromagnetic brain 
activity of AD and control subjects [9]-[11]. Hence, they are 
used here as benchmark for comparison purposes. Fig.10 
shows the boxplots of the RPs for each EEG electrode for 
AD patients and controls subjects. The bottom and top of the 
boxplot show the first and third quartiles respectively, with 
the middle (red) band representing the median (second 
quartile). Outliers are shown as red crosses, with the 
maximum and minimum values of the data after exclusion of 
outliers shown as black bars above and below the boxplot. 
Similarly, Fig.11 and Fig.12 depict the boxplots for MF and 
SE, respectively.  
 
 
 
Fig. 10.  Boxplots with the distributions of RP in δ (‘d’), θ (‘t’), α (‘a’), β 
(‘b’), and γ (‘g’) bands for AD patients and control subjects (‘CN’) at F3, 
F4, O1, and O2.
 
 
Fig. 11.  Boxplots with the distributions of MF for AD patients and control 
subjects (‘CN’) at F3, F4, O1, and O2. 
 
 
Fig. 12.  Boxplots with the distributions of SE for AD patients and control 
subjects (‘CN’) at F3, F4, O1, and O2. 
 
Student’s t-tests indicated that there were significant 
differences (p-value<0.01) between AD patients and control 
subjects at electrodes F3 for MF, SE, RPδ, RPθ, RPα, and 
RPβ; at F4 for MF, SE, RPθ, and RPβ; at O1 for RPδ, RPθ, 
and RPα; and at O2 for RPδ, RPθ, and RPα.  The c(f) 
between the pairs of electrodes F3-O1 and F4-O2 was also 
computed. The distribution of the results appears in Fig.13 
as boxplots. In this case, there were no significant 
differences (all p-values >0.10) between AD patients and 
control subjects for the average c(f) in each spectral band. 
Finally, the connectivity result computed with the phase 
slope index yields statistically significant result between the 
pairs of F3-O1at PSIδ and PSIγ , with p-values equal to 0.02.  
     Among the features with significant differences, the 
highest areas under the ROC curve for the separation 
between AD and control subjects were achieved at O1 and 
O2 with the feature RPα (areas of 0.983 and 0.990, 
respectively).
 
Fig. 13.  Boxplots with the distributions of the average c(f) value for the 
pairs of electrodes F3-O1 and F4-O2 in δ (‘d’),   θ (‘t’), α (‘a’), β (‘b’), and 
γ (‘g’) bands for AD patients and control subjects (‘CN’). 
 
C. Combined Feature Analysis 
     We explored combining the best classification features of 
the two approaches (i.e. those with most differentiating 
capability from PDM modeling and from Relative Power 
measurement) and achieved complete separation of patients 
from controls by using the 4th PDM of the O1-F3 system 
and the Relative Power in the alpha band measured at O1 
(Fig.14), or the 4th PDM of the O2-F3 system and the 
Relative Power in the alpha band measured at O2 (Fig.15). 
 
 
  Fig. 14.  Scatter-plot of computed ANF linear trends (slopes) for 4th 
PDMs of the O1-to-F3 system, corresponding to the theta-delta band, versus 
the Relative Power in O1 corresponding to the alpha band. This 
classification plot shows no false-negatives and no false-positives.
 
Fig. 15.  Scatter-plot of computed ANF linear trends (slopes) for 4th PDMs 
of the O2-to-F3 system, corresponding to the theta-delta band, versus the 
Relative Power in O2 corresponding to the alpha band. This classification 
plot shows no false-negatives and no false-positives. 
IV.  DISCUSSION AND CONCLUSION 
We have presented a methodology for input-output 
modeling of the dynamic relationships between EEG 
recordings in AD patients and control subjects that can be 
used for diagnostic delineation of the two groups.  The 
methodology is based on the concept of Principal Dynamic 
Modes (PDMs) and their associated nonlinear functions 
(ANFs) that has been recently developed and applied 
successfully to various physiological systems. 
Preliminary results of the application of this methodology 
to data collected from 17 AD patients and 24 control 
subjects offer considerable promise. Specifically, when the 
effective gain coefficients of the 2nd and 4th PDMs (i.e. the 
slopes of the linear trends in their respective ANFs) are used 
as classifiers for the O2-F3 system, we have one false-
positve and two false-negatives (see Fig.6) – i.e. 88.2% 
sensitivity and 95.8% specificity.  Likewise, when the 
effective gain coefficients of the 2nd and 4th PDMs are used 
as classifiers for the O1-F3 system, we have two  false-
negatives and two  false-positves (see Fig.9, i.e. 82.3% 
sensitivity and 91.7% specificity). This suggests that the use 
of more than two PDMs/ANFs ought to be explored for 
differentiation of patients from controls. The classification 
line is obtained through nonlinear regression. The ROC 
curve also demonstrates promising performance of these 
classifiers (see Fig.7).  The best classifiers for both O1-F3 
and O2-F3 systems corresponded to the PDMs with theta-
delta spectral characteristics, consistent with previously 
reported observations of increased theta and delta activity 
in the left hemispheric frontal region in AD patients 
compared to control subjects, as well as decreased alpha 
activity in AD patients [1]-[3]. If these results become 
confirmed in larger numbers of subjects, then the proposed 
approach will offer a valuable non-invasive diagnostic tool 
for AD. These initial results are consistent with the current 
view that elevated theta activity in the awake adult may 
indicate abnormal neurological conditions, and reduced 
alpha activity may reflect (in part) a state of heightened 
anxiety in AD patients. We note, however, that our PDM-
based analysis yields classification features that concern the 
causal relation between two EEG signals (e.g. O1 as a 
putative “input” and F3 as a putative “output”), while 
activity within a neural-rhythm band concerns simply the 
spectral characteristics of the signals themselves.    
Even though the coherence c(f) only captures linear 
interactions between signals, previous research has 
suggested that it is strongly correlated with other commonly 
used synchronization measures [14]. However, there have 
been differences in the findings of previous studies about 
how AD affects brain connectivity. This might be due to 
differences in the analyzed populations, the heterogeneity of 
the disease and small differences in the connectivity metrics 
[15]. The use of PDM-based connectivity models addresses 
some of these issues by extending the analysis of the data 
into the nonlinear domain and, more importantly, by 
focusing on the dynamic relation between two EEG signals 
(measured at the frontal and occipital lobes in this case) and 
not the temporal or spectral structure of the signals 
themselves.  This distinction may prove useful because it 
removes part of the potential ambiguity in differentiating 
patients from controls by virtue of the fact that the employed  
"classification feature" (i.e. the slope of the ANFs in this 
case) is independent of the particular neural activity that 
defines the spectro-temporal signal structure at the time of 
data collection.  In other words, the PDM-based approach 
focuses on the system between the two signals and not on 
the signals themselves.  
We examined the correlation between the PDM gain that 
yielded the best classification result (PDM4 in the O2-to-F3) 
and the Relative Power in O2 corresponding to theta band 
(RPθ) that is dominant in PDM4. This correlation is 
statistically significant with correlation coefficient of 0.81 
and p-value less than 0.0001. Similar result was obtained 
between the PDM4 in the O1-to-F3 system (delta-theta band) 
and the RPθ in O1(correlation coefficient equal to 0.82 and 
p-value < 0.0001). Similarly, the most delineating features in 
the benchmark study: RPα in O1 and O2, also correlate with 
their PDM counterparts (gain of PDM2 corresponding to the 
alpha band) with correlation coefficient equal to 0.3 and p-
value < 0.05. These findings suggest that the RP 
measurements in theta and alpha band achieve similar 
delineation between patients and controls as PDM analysis.  
It was shown that perfect delineation between patients and 
controls was achieved when the best PDM and RP features 
were combined (see Fig.14 and Fig.15). 
The findings of the PDM analysis imply that AD patients 
may have slower neural connectivity than controls between 
the occipital and the frontal cortical regions, as suggested by 
the higher gains in theta band and lower gains in alpha band. 
This is consistent with current views of the progressive 
impairment of cortical connectivity in neurodegenerative 
diseases. 
Although our sample size is insufficient to prove the 
clinical utility of the reported EEG analyses for AD 
diagnosis, it is beneficial to relate our research to the current 
framework for AD diagnosis in clinical practice and research 
[8], [18]. Current criteria distinguish between the 
pathological process of AD and the observable symptoms 
caused by that process [8], [18]. Whereas the clinical 
diagnosis of AD must be performed using only the patient’s 
cognitive and behavioral symptoms [8], a few biomarkers 
(magnetic resonance imaging, biochemical levels in the 
cerebrospinal fluid, specific genetic factors and positron 
emission tomography) can increase or decrease the certainty 
that clinical symptoms are due to an underlying AD 
pathology [8], [18]. Although EEG is not currently included 
in such list of biomarkers, it provides a direct measure of the 
brain activity. Furthermore, it is noninvasive and affordable. 
Therefore, it holds promise to become, after suitable signal 
processing, a widely available method to support clinicians 
in the diagnosis of the disease.  
Our preliminary results are promising but they are 
inevitably affected by various sources of errors, including 
the variability in physiological mechanisms and 
measurement instrumentation. Therefore, these potential 
errors must be further examined in future studies.  We must 
emphasize that the sensitivity of parameter selection for 
model estimation is a critical issue for the reproducibility of 
results in a clinical context and, therefore, it should be 
examined in future studies with larger sample size and 
different clinical settings. 
Another limitation of this study is that the average ages of 
the two subject groups were different. However, the AD 
patients were recruited following standard clinical 
procedures and the dataset have been used in a number of 
research studies [12]. Moreover, the probable AD subjects 
had not previously been diagnosed (prior to the assessment 
at the memory clinic that led to their referral to the EEG 
department). Thus, they were in the early stages of 
exhibiting clinical symptoms. Finally, the subjects did not 
perform any task. Hence, the classification performance 
might improve by analyzing signals acquired during specific 
experimental settings [14]. 
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